Fierce Pharma Biopharma News & Insights
WEB5 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
WEBSep 28, 2018 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...
With Sandoz contract expiring, GSK will close plant in UK
WEBSep 9, 2024 · With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing facility in its home country. The U.K. pharma will close its plant in ...
CordenPharma earmarks $981M for manufacture of GLP-1 products
WEBJul 16, 2024 · CordenPharma GLP-1 CDMO Vifor Pharma. CordenPharma will invest 900 million euros ($981 million) over the next three years to bolster its ability to manufacture GLP-1 peptides in Europe and the ...
The top 10 vaccine companies worldwide - Fierce Pharma
WEBWhat a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
DEA raises production quota on Takeda's ADHD drug Vyvanse
WEBSep 4, 2024 · The DEA has raised the aggregate production quota on lisdexamfetamine by 6,236 kilograms, according to a final order set to be published Thursday in the Federal Register. Of that figure, 1,558 kg ...
Novartis sues FDA after it approves generic version of Entresto
WEBAug 1, 2024 · The petition, which was submitted in September 2022, had asked the agency to deny the approval of any Entresto generic until Feb. 16 of this year. It also petitioned to prevent the FDA from ...
Eli Lilly's Mounjaro, Zepbound back in stock after extended …
WEBBy Zoey Becker Aug 5, 2024 10:57am. Mounjaro Zepbound Eli Lilly tirzepatide. Months of an ongoing supply squeeze for Eli Lilly’s tirzepatide-based meds have lifted, according to the FDA. After ...
Travere's IgAN drug Filspari wins full FDA approval
WEBSep 5, 2024 · So far, Filspari’s launch has been going well. The drug brought in $27.1 million in sales in the second quarter of the year, coming 37% above the prior quarter and ahead of analysts’ consensus ...
The top 15 blockbuster patent expirations coming this decade
WEBJul 12, 2021 · The biggest names set to face generic pressure in the coming years include the top four of the industry’s best-selling drugs in 2020: Humira, Keytruda, Revlimid and Eliquis. In all, nine of the ...